Key Takeaways MED emphasizes metabolic health as GLP-1 drugs reshape weight-loss and wellness trends.Clinical results show 98% lean mass retention and 14% visceral fat reduction in 16-week programs.Digital tools, Premier plus pricing and EDGE coaching aim to boost retention and support 2026 growth.Medifast, Inc. (MED) recognizes that the weight-loss and wellness landscape has evolved quickly as GLP-1 drugs gain wider adoption, reshaping how obesity and health are viewed by offering an effective way to suppr ...